Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-aminobutyric acid A receptor modulators are compounds that modulate the activity of the GABA<sub>A</sub> receptor, a major inhibitory neurotransmitter receptor in the central nervous system. These modulators can be either positive allosteric modulators (PAMs), which enhance the effect of GABA, or negative allosteric modulators (NAMs), which inhibit it. The GABA<sub>A</sub> receptor is an ionotropic, ligand-gated chloride channel composed of various subunits. Allosteric modulators bind at sites distinct from where GABA binds, altering receptor function without directly activating or blocking it. PAMs are widely used therapeutically for their sedative-hypnotic and anxiolytic properties, while NAMs may have cognitive-enhancing or antidepressant properties in selective cases. Dysfunctional modulation can contribute to neurological diseases such as epilepsy.
Allosteric modulation of GABA<sub>A</sub> receptor activity; enhancement or inhibition of GABA-induced chloride ion influx.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid A Receptor Modulator.